Journal
Therapeutic Advances in Hematology
Publication Date
3-13-2024
Volume
15
First Page
20406207241237607
Document Type
Open Access Publication
DOI
10.1177/20406207241237607
Rights and Permissions
Kong T, Gaudin N, Gordon K, Cox MJ, Zhou AW, Oh ST. A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis. Ther Adv Hematol. 2024 Mar 13;15:20406207241237607. doi: 10.1177/20406207241237607. © The Author(s), 2024. Creative Commons License (CC BY-NC 4.0) This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Recommended Citation
Kong, Tim; Gaudin, Nicole; Gordon, Karyn; Cox, Maggie J; Zhou, Amy W; and Oh, Stephen T, "A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis." Therapeutic Advances in Hematology. 15, 20406207241237607 (2024).
https://digitalcommons.wustl.edu/oa_4/3423
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
